| 0 (0%) | 09-27 09:32 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 22.74 | 1-year : | 26.56 |
| Resists | First : | 19.46 | Second : | 22.74 |
| Pivot price | 18.25  |
|||
| Supports | First : | 17.3 |
Second : | 15.97 |
| MAs | MA(5) : | 18.73 |
MA(20) : | 18.2 |
| MA(100) : | 14.48 |
MA(250) : | 9.56 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 60.3 |
D(3) : | 67.8 |
| RSI | RSI(14): 57 |
|||
| 52-week | High : | 19.46 | Low : | 3.77 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ OPRX ] has closed below upper band by 27.5%. Bollinger Bands are 33.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 18.93 - 19.04 | 19.04 - 19.15 |
| Low: | 18.21 - 18.34 | 18.34 - 18.47 |
| Close: | 18.57 - 18.77 | 18.77 - 18.96 |
Tue, 23 Sep 2025
OptimizeRx Corporation's (NASDAQ:OPRX) Shift From Loss To Profit - simplywall.st
Thu, 11 Sep 2025
Insider Sale: Director at $OPRX Sells 11,120 Shares - Quiver Quantitative
Thu, 11 Sep 2025
475,000 Shares in OptimizeRx Corp. $OPRX Bought by Parkman Healthcare Partners LLC - MarketBeat
Wed, 10 Sep 2025
Healthcare Tech Leader OptimizeRx Set for Lake Street Capital's Growth Conference Presentation - Stock Titan
Mon, 01 Sep 2025
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Tue, 19 Aug 2025
Major C-Suite Overhaul: OptimizeRx Names 6 Top Executives to New Roles in Healthcare Tech Growth Push - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 19 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 15.1 (%) |
| Held by Institutions | 71.2 (%) |
| Shares Short | 1,350 (K) |
| Shares Short P.Month | 1,140 (K) |
| EPS | -0.55 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.42 |
| Profit Margin | -9.5 % |
| Operating Margin | 10.9 % |
| Return on Assets (ttm) | 1.3 % |
| Return on Equity (ttm) | -8.3 % |
| Qtrly Rev. Growth | 55.2 % |
| Gross Profit (p.s.) | 3.63 |
| Sales Per Share | 5.64 |
| EBITDA (p.s.) | 0.42 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 10 (M) |
| Levered Free Cash Flow | 12 (M) |
| PE Ratio | -34.78 |
| PEG Ratio | 0 |
| Price to Book value | 2.92 |
| Price to Sales | 3.32 |
| Price to Cash Flow | 33.5 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|